Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2021 / N 4

Роль системы комплемента в поражении почек у пациентов с COVID-19
А.П. Бобков, С.С. Стоянова, Л.Я. Французевич, А.Н. Алёшина, Е.А. Мершина, Л.М. Самоходская, Т.Н. Краснова, В.Е. Синицын, Е.П. Павликова, А.А. Камалов

Список литературы

1. International Society of Nephrology. Initiatives. COVID-19. Recommendations. Available from: https://www.theisn.org/initiatives/covid-19/recommendations/#covid-19-in-patients-with-chronic-kidney-disease Accessed 2022 Feb 24.
2. Ahmadian E, Hosseiniyan Khatibi SM, Razi Soofiyani S, Abediazar S, Shoja MM, Ardalan M, Zununi Vahed S. Covid-19 and kidney injury: pathophysiology and molecular mechanisms. Reviews in Medical Virology 2021 May;31(3):e2176.
3. Klein F, Soriano JC, Anfuso MB, Ruiz V, Perazzo M, Paladini H, Vigliano A, Ossés J, Lowenstein P, Vigliano C, Cáneva J. Transbronchial biopsies’ histopathological findings leading to successful late steroid therapy in Covid-19 acute respiratory failure. Virchows Archiv 2021 Oct;479(4):827-33.
4. Laurence J, Mulvey JJ, Seshadri M, Racanelli A, Harp J, Schenck EJ, Zappetti D, Horn EM, Magro CM. Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19. Clinical Immunology (Orlando, Fla.) 2020 Oct;219:108555.
5. Santiesteban-Lores LE, Amamura TA, da Silva TF, Midon LM, Carneiro MC, Isaac L, Bavia L. A double edged-sword – the complement system during SARS-CoV-2 infection. Life Sciences 2021 May;272:119245.
6. De Vriese AS, Sethi S, Van Praet J, Nath KA, Fervenza FC. Kidney disease caused by dysregulation of the complement alternative pathway: an etiologic approach. Journal of the American Society of Nephrology 2015 Dec;26(12):2917-29.
7. Kurts C, Panzer U, Anders HJ, Rees AJ. The immune system and kidney disease: basic concepts and clinical implications. Nature Reviews. Immunology 2013 Oct;13(10):738-53.
8. Noris M, Remuzzi G. Overview of complement activation and regulation. Seminars in Nephrology 2013 Nov;33(6):479-92.
9. Diao B, Wang C, Wang R, Feng Z, Zhang J, Yang H, Tan Y, Wang H, Wang C, Liu L, Liu Y, Liu Y, Wang G, Yuan Z, Hou X, Ren L, Wu Y, Chen Y. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nature Communications 2021 May;12(1):2506.
10. Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, Yi F, Yang HC, Fogo AB, Nie X, Zhang C. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney International 2020 Jul;98(1):219-27.
11. Werion A, Belkhir L, Perrot M, Schmit G, Aydin S, Chen Z, Penaloza A, De Greef J, Yildiz H, Pothen L, Yombi JC, Dewulf J, Scohy A, Gérard L, Wittebole X, Laterre PF, Miller SE, Devuyst O, Jadoul M, Morelle J; Cliniques Universitaires Saint-Luc (CUSL) COVID-19 Research Group. SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule. Kidney International 2020 Nov;98(5):1296-307.
12. ACE2 angiotensin converting enzyme 2 [Homo sapiens (human)]. Gene ID: 59272, updated on 20 Feb 2022. Available from: https://www.ncbi.nlm.nih.gov/gene/59272 Accessed 2022 Feb 24.
13. Martinez-Rojas MA, Vega-Vega O, Bobadilla NA. Is the kidney a target of SARS-CoV-2? American Journal of Physiology. Renal Physiology 2020 Jun;318(6):F1454-62.
14. Выхристенко Л.Р., Счастливенко А.И., Бондарева Л.И., Сидоренко Е.В., Музыка О.Г. Поражение почек при инфекции COVID-19. Вестник Витебского государственного медицинского университета 2021;20(1):7-23.
15. Robbins-Juarez SY, Qian L, King KL, Stevens JS, Husain SA, Radhakrishnan J, Mohan S. Outcomes for patients with COVID-19 and acute kidney injury: a systematic review and meta-analysis. Kidney International Reports 2020 Jun;5(8):1149-60.
16. Nadim MK, Forni LG, Mehta RL, Connor MJ Jr, Liu KD, Ostermann M, Rimmelé T, Zarbock A, Bell S, Bihorac A, Cantaluppi V, Hoste E, Husain-Syed F, Germain MJ, Goldstein SL, Gupta S, Joannidis M, Kashani K, Koyner JL, Legrand M, Lumlertgul N, Mohan S, Pannu N, Peng Z, Perez-Fernandez XL, Pickkers P, Prowle J, Reis T, Srisawat N, Tolwani A, Vijayan A, Villa G, Yang L, Ronco C, Kellum JA. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nature Reviews. Nephrology 2020 Dec;16(12):747-64.
17. Pei G, Zhang Z, Peng J, Liu L, Zhang C, Yu C, Ma Z, Huang Y, Liu W, Yao Y, Zeng R, Xu G. Renal involvement and early prognosis in patients with COVID-19 pneumonia. Journal of American Society of Nephrology 2020 Jun;31(6):1157-65.
18. Mohamed MMB, Lukitsch I, Torres-Ortiz AE, Walker JB, Varghese V, Hernandez-Arroyo CF, Alqudsi M, LeDoux JR, Velez JCQ. Acute kidney injury associated with coronavirus disease 2019 in urban New Orleans. Kidney 2020 Jul;1(7):614-22.
19. Ling Y, Xu SB, Lin YX, Tian D, Zhu ZQ, Dai FH, Wu F, Song ZG, Huang W, Chen J, Hu BJ, Wang S, Mao EQ, Zhu L, Zhang WH, Lu HZ. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chinese Medical Journal 2020 May;133(9):1039-43.
20. Peng L, Liu J, Xu W, Luo Q, Chen D, Lei Z, Huang Z, Li X, Deng K, Lin B, Gao Z. SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens. Journal of Medical Virology 2020 Sep;92(9):1676-80.
21. Stolyarevich ES, Frolova NF, Artyukhina LY, Varyasin VV. Kidney damage in Covid-19: clinical and morphological manifestations of renal pathology in 220 patients died from Covid-19. Nephrology and Dialysis 2020;22(S):46-55.
22. Magro CM, Mulvey J, Berlin D, Nuovo GJ, Salvatore S, Harp J, Baxter-Stoltzfus A, Laurence J. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Translational Research 2020 Jun;220:1-13.
23. Tang S, Sheerin NS, Zhou W, Brown Z, Sacks SH. Apical proteins stimulate complement synthesis by cultured human proximal tubular epithelial cells. Journal of the American Society of Nephrology 1999 Jan;10(1):69-76.
24. Ramlall V, Thangaraj PM, Meydan C, Foox J, Butler D, Kim J, May B, De Freitas JK, Glicksberg BS, Mason CE, Tatonetti NP, Shapira SD. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection. Nature Medicine 2020 Oct;26(10):1609-15.
25. Liszewski MK, Java A, Schramm EC, Atkinson JP. Complement dysregulation and disease: insights from contemporary genetics. Annual Review of Pathology 2017 Jan;12:25-52.
26. Ort M, Dingemanse J, van den Anker J, Kaufmann P. Treatment of rare inflammatory kidney diseases: drugs targeting the terminal complement pathway. Frontiers in Immunology 2020 Dec;11:599417.
27. Santiesteban-Lores LE, Amamura TA, da Silva TF, Midon LM, Carneiro MC, Isaac L, Bavia L. A double edged-sword – the complement system during SARS-CoV-2 infection. Life Sciences 2021 May;272:119245.
28. Kellum JA, Lameire N; KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Critical Care 2013 Feb;17(1):204.
29. de Nooijer AH, Grondman I, Janssen NA, Netea MG, Willems L, van de Veerdonk FL, Giamarellos-Bourboulis EJ, Toonen EJM, Joosten LAB; RCI-COVID-19 study group. Complement activation in the disease course of coronavirus disease 2019 and its effects on clinical outcomes. The Journal of Infectious Diseases 2021 Feb;223(2):214-24.
30. Dheir H, Sipahi S, Yaylaci S, Köroğlu M, Erdem AF, Karabay O. Is there relationship between SARS-CoV-2 and the complement C3 and C4? Turkish Journal of Medical Sciences 2020 Jun;50(4):687-8.
31. Cugno M, Meroni PL, Gualtierotti R, Griffini S, Grovetti E, Torri A, Panigada M, Aliberti S, Blasi F, Tedesco F, Peyvandi F. Complement activation in patients with COVID-19: a novel therapeutic target. The Journal of Allergy and Clinical Immunology 2020 Jul;146(1):215-7.
32. Holter JC, Pischke SE, de Boer E, Lind A, Jenum S, Holten AR, Barratt-Due A, Sokolova M, Schjalm C, Chaban V, Kolderup A, Tran T, Gjølberg TT, Skeie LG, Hesstvedt L, Ormåsen V, Fevang B, Austad C, Müller KE, Fladeby C, Holberg-Petersen M, Halvorsen B, Müller F, Aukrust P, Dudman S, Ueland T, Andersen JT, Lund-Johansen F, Heggelund L, Dyrhol-Riise AM, Mollnes TE. Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients. Proceedings of the National Academy of Sciences of the USA 2020 Oct;117(40):25018-25.
33. Yu J, Yuan X, Chen H, Chaturvedi S, Braunstein EM, Brodsky RA. Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition. Blood 2020 Oct 29;136(18):2080-9.
34. Kozma GT, Mészáros T, Bakos T, Hennies M, Bencze D, Uzonyi B, Győrffy B, Cedrone E, Dobrovolskaia MA, Józsi M, Szebeni J. Mini-factor H modulates complement-dependent IL-6 and IL-10 release in an immune cell culture (PBMC) model: potential benefits against cytokine storm. Frontiers in Immunology 2021 Apr;12:642860.

References

1. International Society of Nephrology. Initiatives. COVID-19. Recommendations. Available from: https://www.theisn.org/initiatives/covid-19/recommendations/#covid-19-in-patients-with-chronic-kidney-disease Accessed 2022 Feb 24.
2. Ahmadian E, Hosseiniyan Khatibi SM, Razi Soofiyani S, Abediazar S, Shoja MM, Ardalan M, Zununi Vahed S. Covid-19 and kidney injury: pathophysiology and molecular mechanisms. Reviews in Medical Virology 2021 May;31(3):e2176.
3. Klein F, Soriano JC, Anfuso MB, Ruiz V, Perazzo M, Paladini H, Vigliano A, Ossés J, Lowenstein P, Vigliano C, Cáneva J. Transbronchial biopsies’ histopathological findings leading to successful late steroid therapy in Covid-19 acute respiratory failure. Virchows Archiv 2021 Oct;479(4):827-33.
4. Laurence J, Mulvey JJ, Seshadri M, Racanelli A, Harp J, Schenck EJ, Zappetti D, Horn EM, Magro CM. Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19. Clinical Immunology (Orlando, Fla.) 2020 Oct;219:108555.
5. Santiesteban-Lores LE, Amamura TA, da Silva TF, Midon LM, Carneiro MC, Isaac L, Bavia L. A double edged-sword – the complement system during SARS-CoV-2 infection. Life Sciences 2021 May;272:119245.
6. De Vriese AS, Sethi S, Van Praet J, Nath KA, Fervenza FC. Kidney disease caused by dysregulation of the complement alternative pathway: an etiologic approach. Journal of the American Society of Nephrology 2015 Dec;26(12):2917-29.
7. Kurts C, Panzer U, Anders HJ, Rees AJ. The immune system and kidney disease: basic concepts and clinical implications. Nature Reviews. Immunology 2013 Oct;13(10):738-53.
8. Noris M, Remuzzi G. Overview of complement activation and regulation. Seminars in Nephrology 2013 Nov;33(6):479-92.
9. Diao B, Wang C, Wang R, Feng Z, Zhang J, Yang H, Tan Y, Wang H, Wang C, Liu L, Liu Y, Liu Y, Wang G, Yuan Z, Hou X, Ren L, Wu Y, Chen Y. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nature Communications 2021 May;12(1):2506.
10. Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, Yi F, Yang HC, Fogo AB, Nie X, Zhang C. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney International 2020 Jul;98(1):219-27.
11. Werion A, Belkhir L, Perrot M, Schmit G, Aydin S, Chen Z, Penaloza A, De Greef J, Yildiz H, Pothen L, Yombi JC, Dewulf J, Scohy A, Gérard L, Wittebole X, Laterre PF, Miller SE, Devuyst O, Jadoul M, Morelle J; Cliniques Universitaires Saint-Luc (CUSL) COVID-19 Research Group. SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule. Kidney International 2020 Nov;98(5):1296-307.
12. ACE2 angiotensin converting enzyme 2 [Homo sapiens (human)]. Gene ID: 59272, updated on 20 Feb 2022. Available from: https://www.ncbi.nlm.nih.gov/gene/59272 Accessed 2022 Feb 24.
13. Martinez-Rojas MA, Vega-Vega O, Bobadilla NA. Is the kidney a target of SARS-CoV-2? American Journal of Physiology. Renal Physiology 2020 Jun;318(6):F1454-62.
14. Vykhristenko LR, Schastlivenko AI, Bondareva LI, Sidorenko EV, Muzyka OG. Kidney damage in COVID-19 infection. Bulletin of Vitebsk State Medical University 2021;20(1):7-23 (In Russian).
15. Robbins-Juarez SY, Qian L, King KL, Stevens JS, Husain SA, Radhakrishnan J, Mohan S. Outcomes for patients with COVID-19 and acute kidney injury: a systematic review and meta-analysis. Kidney International Reports 2020 Jun;5(8):1149-60.
16. Nadim MK, Forni LG, Mehta RL, Connor MJ Jr, Liu KD, Ostermann M, Rimmelé T, Zarbock A, Bell S, Bihorac A, Cantaluppi V, Hoste E, Husain-Syed F, Germain MJ, Goldstein SL, Gupta S, Joannidis M, Kashani K, Koyner JL, Legrand M, Lumlertgul N, Mohan S, Pannu N, Peng Z, Perez-Fernandez XL, Pickkers P, Prowle J, Reis T, Srisawat N, Tolwani A, Vijayan A, Villa G, Yang L, Ronco C, Kellum JA. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nature Reviews. Nephrology 2020 Dec;16(12):747-64.
17. Pei G, Zhang Z, Peng J, Liu L, Zhang C, Yu C, Ma Z, Huang Y, Liu W, Yao Y, Zeng R, Xu G. Renal involvement and early prognosis in patients with COVID-19 pneumonia. Journal of American Society of Nephrology 2020 Jun;31(6):1157-65.
18. Mohamed MMB, Lukitsch I, Torres-Ortiz AE, Walker JB, Varghese V, Hernandez-Arroyo CF, Alqudsi M, LeDoux JR, Velez JCQ. Acute kidney injury associated with coronavirus disease 2019 in urban New Orleans. Kidney 2020 Jul;1(7):614-22.
19. Ling Y, Xu SB, Lin YX, Tian D, Zhu ZQ, Dai FH, Wu F, Song ZG, Huang W, Chen J, Hu BJ, Wang S, Mao EQ, Zhu L, Zhang WH, Lu HZ. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chinese Medical Journal 2020 May;133(9):1039-43.
20. Peng L, Liu J, Xu W, Luo Q, Chen D, Lei Z, Huang Z, Li X, Deng K, Lin B, Gao Z. SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens. Journal of Medical Virology 2020 Sep;92(9):1676-80.
21. Stolyarevich ES, Frolova NF, Artyukhina LY, Varyasin VV. Kidney damage in Covid-19: clinical and morphological manifestations of renal pathology in 220 patients died from Covid-19. Nephrology and Dialysis 2020;22(S):46-55.
22. Magro CM, Mulvey J, Berlin D, Nuovo GJ, Salvatore S, Harp J, Baxter-Stoltzfus A, Laurence J. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Translational Research 2020 Jun;220:1-13.
23. Tang S, Sheerin NS, Zhou W, Brown Z, Sacks SH. Apical proteins stimulate complement synthesis by cultured human proximal tubular epithelial cells. Journal of the American Society of Nephrology 1999 Jan;10(1):69-76.
24. Ramlall V, Thangaraj PM, Meydan C, Foox J, Butler D, Kim J, May B, De Freitas JK, Glicksberg BS, Mason CE, Tatonetti NP, Shapira SD. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection. Nature Medicine 2020 Oct;26(10):1609-15.
25. Liszewski MK, Java A, Schramm EC, Atkinson JP. Complement dysregulation and disease: insights from contemporary genetics. Annual Review of Pathology 2017 Jan;12:25-52.
26. Ort M, Dingemanse J, van den Anker J, Kaufmann P. Treatment of rare inflammatory kidney diseases: drugs targeting the terminal complement pathway. Frontiers in Immunology 2020 Dec;11:599417.
27. Santiesteban-Lores LE, Amamura TA, da Silva TF, Midon LM, Carneiro MC, Isaac L, Bavia L. A double edged-sword – the complement system during SARS-CoV-2 infection. Life Sciences 2021 May;272:119245.
28. Kellum JA, Lameire N; KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Critical Care 2013 Feb;17(1):204.
29. de Nooijer AH, Grondman I, Janssen NA, Netea MG, Willems L, van de Veerdonk FL, Giamarellos-Bourboulis EJ, Toonen EJM, Joosten LAB; RCI-COVID-19 study group. Complement activation in the disease course of coronavirus disease 2019 and its effects on clinical outcomes. The Journal of Infectious Diseases 2021 Feb;223(2):214-24.
30. Dheir H, Sipahi S, Yaylaci S, Köroğlu M, Erdem AF, Karabay O. Is there relationship between SARS-CoV-2 and the complement C3 and C4? Turkish Journal of Medical Sciences 2020 Jun;50(4):687-8.
31. Cugno M, Meroni PL, Gualtierotti R, Griffini S, Grovetti E, Torri A, Panigada M, Aliberti S, Blasi F, Tedesco F, Peyvandi F. Complement activation in patients with COVID-19: a novel therapeutic target. The Journal of Allergy and Clinical Immunology 2020 Jul;146(1):215-7.
32. Holter JC, Pischke SE, de Boer E, Lind A, Jenum S, Holten AR, Barratt-Due A, Sokolova M, Schjalm C, Chaban V, Kolderup A, Tran T, Gjølberg TT, Skeie LG, Hesstvedt L, Ormåsen V, Fevang B, Austad C, Müller KE, Fladeby C, Holberg-Petersen M, Halvorsen B, Müller F, Aukrust P, Dudman S, Ueland T, Andersen JT, Lund-Johansen F, Heggelund L, Dyrhol-Riise AM, Mollnes TE. Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients. Proceedings of the National Academy of Sciences of the USA 2020 Oct;117(40):25018-25.
33. Yu J, Yuan X, Chen H, Chaturvedi S, Braunstein EM, Brodsky RA. Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition. Blood 2020 Oct 29;136(18):2080-9.
34. Kozma GT, Mészáros T, Bakos T, Hennies M, Bencze D, Uzonyi B, Győrffy B, Cedrone E, Dobrovolskaia MA, Józsi M, Szebeni J. Mini-factor H modulates complement-dependent IL-6 and IL-10 release in an immune cell culture (PBMC) model: potential benefits against cytokine storm. Frontiers in Immunology 2021 Apr;12:642860.
  

[ Содержание выпуска N 4 | Выпуски журнала | Список журналов ]